Clinical trials exclude many real-world patients: elderly, multi-morbid, pregnant, or those on multiple drugs. Yet real practice involves exactly these populations.
Professionals constantly navigate off-label use not recklessly, but thoughtfully balancing risk and benefit where data is limited.
How comfortable are you practicing in evidence “grey zones”?
MBH/AB